Featured

For many years, the rising complexity of APIs has led to the development of a sea of novel formulations that help in the efficient delivery of drugs to the intended site where action needs to happen. Nevertheless, the demand...

One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11% between 2023 and 2035 and will be driven largely by digital transformation. The influencing factors identified...

Syntegon looks back on a stable business development in 2022. Thanks to its proven machinery and service portfolio, innovative powers, and global footprint with 37 sites in 20 countries, the company increased both order income and sales last year...

A group involving 19 European Union member countries is pushing for steps to lessen the bloc’s dependence when it comes to Chinese imports as far as pharmaceutical ingredients are concerned, according to a paper dated May 2. This move comes...

The EU's drug regulations can get a major makeover soon. In a set of proposals, the European Commission looks to address numerous shortfalls troubling the $148 billion pharmaceutical industry. The proposed upgrades give out the most significant revisions across...

Research co-led by the University of Queensland has found that Australia is falling short of similar countries when it comes to funding basic research, specifically in the medical, biotechnology, and pharmaceutical arenas. The University of Queenland’s School of Chemical...

In December, the European Commission went on to issue the first approval when it comes to allogenic T-cell therapy in the world, which happened to be a prominent milestone when it comes to the cell and gene therapy sector....